1-2 of 2
Maria Angelica Fernández Barbieri
Close
Sort by
Journal Articles

Risk-Adapted Therapy with ABVD for Low- and Intermediate-Risk Patients and Oepa-Copdac for High Risk Patients Plus Involved-Field Radiation Therapy (IFRT) Based on Prognosis at Diagnosis and Early Response: Results from Pediatric Argentinian Collaborative Group Gatla Study for Children and Adolescents with Hodgkin Lymphoma

David Alejandro Veron, MD, Patricia Streitenberger, MD, Cecilia Riccheri, MD, Monica Matus, MD, Pedro Negri Aranguren, MD, Maria Alejandra Costa, MD, Nestor Alfredo Rossi, MD, Elizabeth Hiramatsu, MD, Maria Alejandra Cedola, MD, María Constanza Drozdowski, MD, Sandra Borchichi, MD, Marcelo Coirini, MD, María Cecilia Murray, MD, Karina D'Aloi, MD, Carlos Holmann, MD, Matilde Gomel, MD, Gisela Drago, MD, Horacio Daniel Caferri, MD, Maria Angelica Fernandez Barbieri, MD, Mara Villamil, MD, Claudia Mabel Ruiz, MD, Sandra Ethel Zirone, MD, Monica Makiya, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13.
https://doi.org/10.1182/blood-2020-135945
Published: 2020
Journal Articles

Impact of IKZF1 Deletions and IKZF1 Plus in Pediatric Acute Lymphoblastic Leukemia Outcome

Maria Sara Felice, MD PhD, Patricia Laura Rubio, PhD, Myriam Ruth Guitter, MD, Jorge Gabriel Rossi, PhD, Jorge Alberto Digiorge, PhD, Maria Constanza Guardia, MD, Maria Angelica Fernández Barbieri, Gladys Gutierrez, MD, Ezequiel Recondo, MD, Maria Soledad Vides Herrera, MD, Vanina Livio, MD, Cristina Noemi Alonso, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4091.
https://doi.org/10.1182/blood-2018-99-117709
Published: 2018